Ivan Martin talks about the promise of using cell-based therapies to regenerate joint cartilage.
Advertisement
The Scientist
Most Recent
The recipient of the first synthetic organ transplant—a synthetic trachea seeded with the patient’s own stem cells—is sent home from the hospital.
South Korea approves the first stem-cell medication for clinical use.
Three RNAs expressed in the nucleolus mediate death in cells exposed to too much fat.
A certain type of neural precursor does it all—replaces itself, differentiates into specialized brain cells, and multiplies into more stem-cell-like cells.
A new study finds that more than two thirds of Americans approve of the use of stem cells in research aiming to cure serious diseases.
The story of the US government’s efforts to stamp out smallpox in the early 20th century offers insights into the science and practice of mass vaccination.
In Chapter 5, "The Stable and the Laboratory," author Michael Willrich explores the burgeoning vaccine manufacture industry that ramped up to combat smallpox epidemics in turn-of-the-twentieth-century American cities.
Studying the earliest events in visual development, Carla Shatz has learned the importance of looking at one’s data with open eyes—and an open mind.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
